See also this year's filing and all EDGAR filings for this company.
PDF Report 0001385818_2023_AYTU_BIOPHARMA_INC.pdf
Logs
Graph
Absolute values for 0001385818, AYTU BIOPHARMA INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 59,929,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 70,632,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 7,062,000 |
| 4 | LiabilitiesCurrent | 64,442,000 |
| 5 | LiabilitiesNoncurrent | 12,810,000 |
| 6 | remainder_Liabilities | 14,279,000 |
| 7 | CostOfGoodsAndServicesSold | 44,386,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 31,167,000 |
| 9 | ResearchAndDevelopmentExpense | 14,439,000 |
| 10 | remainder_Expenses | 118,128,000 |
| 11 | remainder_Revenues | 96,669,000 |
| 12 | remainder_NetIncome | 1,278,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 137,623,000 |
| 1 | Liabilities | 91,531,000 |
| 2 | Expenses | 208,120,000 |
| 3 | Revenues | 96,669,000 |
| 4 | StockholdersEquity | 46,092,000 |
| 5 | NetIncome | -110,173,000 |
| 6 | ComprehensiveNetIncome | -110,173,000 |
| 7 | BaseVar | 267,610,500 |
| 8 | EconomicCapitalRatio | -0.270 |